SSI Mantra Creates Global Footprint: Nepal’s First Surgical Robot Set to Transform Healthcare Sector
SS Innovations, the developer of India’s first indigenous surgical robotic
AIMS Faridabad is hosting a week-long celebration to honor its
Delhi AIIMS to resume OPD services after 3 months amid COVID-19
The outpatient department (OPD) services at AIIMS, Delhi are set to resume from June 25, after being shut for almost three months due to
Cipla launches Cipremi (remdesivir lyophilised powder for injection 100 mg), the only U.S. FDA approved Emergency Use Authorisation (EUA) treatment for patients with severe COVID-19 disease
Cipla Limited (BSE: 500087; NSE: CIPLA EQ, hereinafter referred to as “Cipla”), today announced the launch of remdesivir under its brand name CIPREMI. The
Blood Plasma Therapy Works For COVID-19, Confirms Mayo Study
Blood plasma products manufacturing company urges government to support plasma therapy for COVID care For those worried about using plasma therapy against COVID-19, there's some
India’s 1st COVID-19 drug FabiFlu launched, priced at ₹103/tablet
Drug firm Glenmark Pharmaceuticals on Saturday said that it has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients
WHO reports record daily increase in global coronavirus cases
The World Health Organisation reported a record increase in global coronavirus cases on Sunday, with the total rising by 183,020 in 24-hour period. The
India playing role of ‘pharmacy of world’: Shanghai Cooperation Org
India is playing the role of the "pharmacy of the world" during the COVID-19 pandemic, Shanghai Cooperation Organisation Secretary-General Vladimir Norov has said. India
Kerala man suffers liver damage after drinking bogus COVID-19 herbal drink
A Kerala man suffered fulminant liver failure and is on ventilator support after consuming a herbal concoction that claimed to prevent coronavirus. Doctor Varun
Hetero, Cipla get nod to make remdesivir to treat Indian COVID-19 patients
Cipla and Hetero Drugs have been granted emergency use approval of antiviral drug remdesivir by drug regulatory body CDSCO. The approvals will allow them